摘要
目的观察六味地黄汤对血液透析患者肝肾阴虚型血小板减少症(HIT)的治疗效果。方法84例血液透析肝肾阴虚型HIT患者随机分为观察组与对照组各42例。对照组给予常规西医治疗,观察组在对照组基础上加用六味地黄汤治疗。两组疗程均为1个月。比较两组治疗前后肝肾阴虚证候积分变化及中医证候疗效;比较两组治疗前后血小板计数(Plt)、P-选择素水平、HIT抗体阳性率变化,以及两组Plt回升时间、临床疗效和不良反应发生率。结果治疗1个月后,两组肝肾阴虚证候积分均较前降低(P<0.05),且观察组低于对照组(P<0.05);观察组中医证候总有效率(97.62%)高于对照组(P<0.05)。治疗14 d后,两组Plt均较前升高,P-选择素水平、HIT抗体阳性率则较前降低(P<0.05),且观察组Plt高于对照组,P-选择素水平、HIT抗体阳性率低于对照组(P<0.05)。观察组Plt回升时间短于对照组(P<0.05),临床总有效率(95.24%)高于对照组(P<0.05);两组治疗期间不良反应发生率差异无统计学意义(P>0.05)。结论常规西医联合六味地黄汤治疗血液透析患者的肝肾阴虚型HIT,可提高临床疗效,减轻患者临床症状,提高Plt,缩短Plt回升时间,降低P-选择素水平和HIT抗体阳性率,且安全性良好,值得临床推广。
Objective To explore the clinical effect of Liuwei Dihuang decoction on thrombocytopenia(HIT)of liver and kidney yin deficiency in hemodialysis patients.Methods 84 hemodialysis patients with liver and kidney yin deficiency HIT were randomly divided into observation group and control group,with 42 cases in each group.The control group was treated with conventional western medicine,while the observation group was treated with Liuwei Dihuang decoction on the basis of the control group.The scores of liver and kidney yin deficiency syndrome before and after treatment and the curative effect of traditional Chinese medicine syndrome were compared between the two groups,and the platelet count(Plt),P-selectin level,HIT antibody before and after treatment,the platelet recovery time and clinical efficacy and adverse reactions of the two groups were also compared.Results After 1 month of treatment,the scores of liver and kidney yin deficiency syndrome in the two groups were both lower than those before treatment(P<0.05),which in the observation group was lower than that of the control group(P<0.05).The total effective rate of traditional Chinese medicine syndromes in the observation group(97.62%)was higher than that in the control group(P<0.05).After 14 d of treatment,the Plt of the two groups were both higher than those before treatment,while the levels of P-selectin and the positive rate of HIT antibody of the two groups were lower than those before treatment(P<0.05),and the Plt in the observation group was higher than that of the control group,the levels of P-selectin and the positive rate of HIT antibody in the observation group were lower than those in the control group(P<0.05).The platelet recovery time in the observation group was shorter than that in the control group(P<0.05),the total effective rate of clinical treatment in the observation group(95.24%)was higher than that in the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups during treatment(P>
作者
曹蓉
魏华娟
孙姗姗
秦娜
刘伟花
孙丽燕
Rong CAO;Hua-Juan WEI;Shan-Shan SUN;Na QIN;Wei-Hua LIU;Li-Yan SUN(Department of Nephrology,Shijiazhuang Municipal Hospital of Traditional Chinese Medicine,Shijiazhuang 050000,China;Department of Rehabilitation,Shijiazhuang Municipal Hospital of Traditional Chinese Medicine,Shijiazhuang 050000,China;Department of Geriatrics,Shijiazhuang Municipal Hospital of Traditional Chinese Medicine,Shijiazhuang 050000,China)
出处
《药物流行病学杂志》
CAS
2023年第12期1354-1361,共8页
Chinese Journal of Pharmacoepidemiology
基金
河北省中医药管理局中医药类科研计划课题项目(2019429)。
关键词
六味地黄汤
血液透析
肝肾阴虚型
血小板减少症
临床疗效
血小板计数
Liuwei Dihuang decoction
Hemodialysis
Liver and kidney Yin deficiency
Thrombocytopenia
Clinical efficacy
Platelet count
